Impact of baseline characteristics on clinical remission achievement in severe asthma
C. Domingo Ribas (Barcelona, Spain), I. Pavord (Oxford, United Kingdom), D. Bañas Conejero (Madrid, Spain), R. Price (Stevenage, Hertfordshire, United Kingdom), A. Pullan (Knutsford, Cheshire, United Kingdom), J. Oppenheimer (Newark, NJ, United States), L. Heaney (Belfast, United Kingdom), H. Nagase (Tokyo, Japan), E. Pizzichini (Santa Catarina, Brazil; and Brentford, Middlesex, United Kingdom), P. Howarth (Brentford, Middlesex, United Kingdom), F. Gardiner (Brentford, Middlesex, United Kingdom)
Source: International Congress 2022 – Asthma treatment: real-world studies and other diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Domingo Ribas (Barcelona, Spain), I. Pavord (Oxford, United Kingdom), D. Bañas Conejero (Madrid, Spain), R. Price (Stevenage, Hertfordshire, United Kingdom), A. Pullan (Knutsford, Cheshire, United Kingdom), J. Oppenheimer (Newark, NJ, United States), L. Heaney (Belfast, United Kingdom), H. Nagase (Tokyo, Japan), E. Pizzichini (Santa Catarina, Brazil; and Brentford, Middlesex, United Kingdom), P. Howarth (Brentford, Middlesex, United Kingdom), F. Gardiner (Brentford, Middlesex, United Kingdom). Impact of baseline characteristics on clinical remission achievement in severe asthma. 1344
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|